Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 1;55(Suppl 1):i31-i37.
doi: 10.1093/ejcts/ezy444.

Current perspectives on mechanical circulatory support

Rene Schramm  1 , Michiel Morshuis  1 , Michael Schoenbrodt  1 , Jochen Boergermann  2 , Kavous Hakim-Meibodi  1 , Masatoshi Hata  1 , Jan F Gummert  1
Affiliations
Review

Current perspectives on mechanical circulatory support

Rene Schramm et al. Eur J Cardiothorac Surg. .

Abstract

Mechanical circulatory support gained a significant value in the armamentarium of heart failure therapy because of the increased awareness of the prevalence of heart failure and the tremendous advances in the field of mechanical circulatory support during the last decades. Current device technologies already complement a heart transplant as the gold standard of treatment for patients with end-stage heart failure refractory to conservative medical therapy. This article reviews important aspects of mechanical circulatory support therapy and focuses on currently debated issues.

Keywords: Biventricular assist device; Left ventricular assist device; Mechanical circulatory report; Total artificial heart.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
(A) Less invasive left ventricular assist device (LVAD) implantation techniques may preserve pericardial integrity and facilitate later median sternotomy in bridge to transplant patients. (B) Chest radiograph showing 2 centrifugal continuous flow pumps (HeartWare HVAD®, Medtronic, Minneapolis, MN, USA) for biventricular support. (C) A perfectly aligned inflow cannula of the Heartmate 3® within the inflow of the left ventricle and away from the septum may prevent low flow and pump thrombosis. (D) Pump thrombosis is a major complication in LVAD therapy. The image shows the impeller of an explanted HeartWare ventricular assist device with fibrin coating. (E) Peripheral driveline infections may be treated by antibiotic and local surgical means. (F) Positron emission tomography-computed tomography scans may uncover ascending infection of the LVAD, here a Heartmate II.
None
See this image and copyright information in PMC

References

    1. Previato M, Osto E, Kerkhof PLM, Parry G, Tona F.. Heart transplantation survival and sex-related differences. Adv Exp Med Biol 2018;1065:379–88. - PubMed
    1. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD. et al. HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885–96. - PubMed
    1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS. et al.; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129–200. - PubMed
    1. Guenther SP, Brunner S, Born F, Fischer M, Schramm R, Pichlmaier M. et al. When all else fails: extracorporeal life support in therapy-refractory cardiogenic shock. Eur J Cardiothorac Surg 2016;49:802–9. - PubMed
    1. Schibilsky D, Kruger T, Lausberg HF, Eisenlohr C, Haller C, Nemeth A. et al. Impella 5.0 as a second-line mechanical circulatory support strategy after extracorporeal life support. Artif Organs 2016;40:909–16. - PubMed